In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
Subscribe To Our Newsletter & Stay Updated
